Cramer Rosenthal McGlynn’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-19,181
Closed -$3.17M 103
2023
Q2
$3.17M Sell
19,181
-4,830
-20% -$780K 0.16% 94
2023
Q1
$3.72M Sell
24,011
-159
-0.7% -$25.7K 0.17% 94
2022
Q4
$4.27M Buy
24,170
+1,164
+5% +$201K 0.19% 90
2022
Q3
$3.76M Buy
23,006
+973
+4% +$165K 0.18% 93
2022
Q2
$3.91M Sell
22,033
-1,589
-7% -$283K 0.18% 90
2022
Q1
$4.19M Sell
23,622
-167
-0.7% -$28.4K 0.16% 88
2021
Q4
$4.07M Buy
23,789
+2,745
+13% +$449K 0.13% 86
2021
Q3
$3.4M Sell
21,044
-1,261
-6% -$215K 0.12% 91
2021
Q2
$3.67M Sell
22,305
-224
-1% -$37.1K 0.12% 90
2021
Q1
$3.7M Sell
22,529
-3,970
-15% -$642K 0.12% 89
2020
Q4
$4.17M Sell
26,499
-461
-2% -$68K 0.13% 86
2020
Q3
$4.01M Sell
26,960
-19,453
-42% -$2.88M 0.16% 84
2020
Q2
$6.53M Sell
46,413
-39,397
-46% -$5.74M 0.26% 82
2020
Q1
$11.3M Sell
85,810
-8,428
-9% -$1.2M 0.53% 71
2019
Q4
$13.7M Sell
94,238
-8,618
-8% -$1.17M 0.39% 93
2019
Q3
$13.3M Sell
102,856
-6,894
-6% -$908K 0.38% 92
2019
Q2
$15.3M Sell
109,750
-42,906
-28% -$5.94M 0.42% 87
2019
Q1
$21.3M Buy
+152,656
New +$20.4M 0.51% 75
2016
Q1
Sell
-115
Closed -$12K 218
2015
Q4
$12K Hold
115
﹤0.01% 228
2015
Q3
$11K Hold
115
﹤0.01% 231
2015
Q2
$11K Hold
115
﹤0.01% 219
2015
Q1
$12K Sell
115
-491,560
-100% -$50M ﹤0.01% 222
2014
Q4
$51.4M Sell
491,675
-509,951
-51% -$53.7M 0.53% 77
2014
Q3
$107M Sell
1,001,626
-283,075
-22% -$29.4M 1.07% 31
2014
Q2
$134M Sell
1,284,701
-45,996
-3% -$4.65M 1.08% 25
2014
Q1
$131M Buy
1,330,697
+595,592
+81% +$55.2M 1% 27
2013
Q4
$67.3M Buy
735,105
+732,355
+26,631% +$67.5M 0.48% 71
2013
Q3
$238K Hold
2,750
﹤0.01% 236
2013
Q2
$236K Buy
+2,750
New +$233K ﹤0.01% 244

Other funds holding JNJ

Cramer Rosenthal McGlynn's JNJ Position: Q3 2023 in Review

Cramer Rosenthal McGlynn sold out of Johnson & Johnson (JNJ) in Q3 2023, closing a stake of 19,181 shares — an estimated $3.17M sold.

Cramer Rosenthal McGlynn first reported a position in JNJ in Q2 2013 and held it in 29 quarters. The position peaked at $134M in Q2 2014. 3,678 funds tracked by Wall St. Rank hold JNJ as of Q3 2023.

  • Cramer Rosenthal McGlynn reported no remaining Johnson & Johnson position as of Q3 2023 after selling out during the quarter.
  • Cramer Rosenthal McGlynn sold 19,181 Johnson & Johnson shares in Q3 2023, an estimated $3.17M.
  • Cramer Rosenthal McGlynn first reported a position in Johnson & Johnson in Q2 2013 and held it in 29 quarters.
  • Cramer Rosenthal McGlynn's Johnson & Johnson position peaked at $134M in Q2 2014.
  • 3,678 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2023.

Based on Cramer Rosenthal McGlynn's 13F filing for Q3 2023, filed 13 Nov 2023.